Pfizer Invests $743 Million to Expand Singapore API Manufacturing Facility

Pfizer stated on the Singapore Economic Development Board's website on July 23 that Pfizer has invested S$1 billion ($743 million) to expand its automated active pharmaceutical ingredient manufacturing facility in Singapore, which will create more than 250 new high-skilled jobs, adding to the hundreds of employees already working in Singapore. (Jiemian)Original link